ALA vs. DHA vs. EPA: The Three Omega-3s Explained

Pick up almost any supplement, food product, or nutrition article that mentions omega-3, and you will eventually run into one or more of three abbreviations: ALA, EPA, and DHA. They all belong to the omega-3 family, and that shared label creates a reasonable but misleading assumption that they are more or less the same thing in different forms. They are not. They have different structures, different dietary sources, different biological functions, and very different practical implications for supplementation and health. Treating them as equivalent leads to real nutritional errors that affect a surprising number of people who think they are adequately supplementing omega-3.

This article explains each one clearly and precisely, covers how they relate to each other, and clarifies why the differences matter for practical decisions about diet and supplementation.

What Makes a Fatty Acid an Omega-3

Before separating the three, it helps to understand what they share. Fatty acids are chains of carbon atoms with hydrogen atoms attached and a carboxylic acid group at one end. The “omega” notation refers to where the first double bond in the carbon chain occurs, counted from the methyl end of the molecule (the end opposite the carboxylic acid group). Omega-3 fatty acids have their first double bond at the third carbon from the methyl end. This structural feature gives them their characteristic chemical behavior and makes them distinct from omega-6 fatty acids, which have their first double bond at the sixth carbon.

Beyond that shared feature, ALA, EPA, and DHA differ substantially in chain length (the number of carbon atoms), the number of double bonds, and the biological processes they participate in. These structural differences translate into dramatically different functional roles in the body.

ALA: The Plant-Based Omega-3

Alpha-linolenic acid (ALA) is an 18-carbon omega-3 fatty acid with three double bonds. It is the most abundant omega-3 in the plant kingdom and the only omega-3 fatty acid classified as “essential” in the strictest nutritional sense, meaning the body cannot synthesize it at all and must obtain it entirely from the diet. ALA is found in meaningful amounts in flaxseed, chia seeds, hemp seeds, walnuts, edamame, and some leafy vegetables. Certain plant-based cooking oils, particularly flaxseed oil, hemp oil, and canola oil, are concentrated sources.

ALA’s primary biological role is as a source of calories and as a precursor for the longer-chain omega-3 fatty acids EPA and DHA. In the body, ALA can be elongated and desaturated through a series of enzymatic reactions into EPA and then further into DHA. This conversion pathway exists in humans and is the reason why ALA is nutritionally relevant even in the absence of direct EPA and DHA consumption.

The Conversion Problem

The conversion of ALA to EPA and DHA is the single most important thing to understand about ALA, because it is the source of the most consequential misunderstanding in omega-3 nutrition. The conversion is real but highly inefficient. Research estimates that somewhere between three and ten percent of dietary ALA is converted to EPA in humans, and less than one percent of dietary ALA ultimately reaches DHA. These numbers vary by individual, sex (women convert slightly more efficiently than men, possibly due to hormonal influences), and dietary context, particularly how much competing omega-6 fatty acid is present in the diet.

The practical consequence is that eating ALA-rich plant foods does not reliably raise EPA or DHA tissue levels in any meaningful way. A tablespoon of flaxseed oil provides around 7 grams of ALA, of which perhaps 200 to 700 mg becomes EPA in a person with average conversion efficiency, and of which perhaps 50 mg or less eventually becomes DHA. These amounts are well below the 250 to 500 mg of combined EPA and DHA per day associated with health maintenance, let alone the 1,000 to 3,000 mg per day used in therapeutic research. You would need to eat implausibly large amounts of flaxseed to compensate for the absence of direct EPA and DHA in the diet through conversion alone.

ALA is nonetheless a genuine essential nutrient with its own metabolic importance beyond serving as an EPA and DHA precursor. Adequate ALA intake supports the balance of the body’s essential fatty acid pools and provides energy substrate. The error is treating ALA adequacy as equivalent to EPA and DHA adequacy, which it is not.

EPA: The Anti-Inflammatory Omega-3

Eicosapentaenoic acid (EPA) is a 20-carbon omega-3 fatty acid with five double bonds. It is found almost exclusively in marine sources, primarily fatty fish, shellfish, and the microalgae that form the base of the marine food chain. EPA in algae oil supplements is produced directly by the algae; EPA in fish oil supplements comes from fish that accumulated it by eating algae.

EPA’s primary biological roles are functional and regulatory rather than structural. It is the omega-3 fatty acid most directly involved in the eicosanoid pathway, the body’s inflammatory signaling system. EPA competes with arachidonic acid (AA), the omega-6 fatty acid that is the dominant precursor for pro-inflammatory eicosanoids, for the cyclooxygenase and lipoxygenase enzymes that produce these signaling molecules. EPA-derived eicosanoids are generally less potent and less pro-inflammatory than AA-derived variants, so increasing the EPA-to-AA ratio in cell membranes shifts the body’s inflammatory signaling toward a less aggressively inflammatory profile.

EPA is also the precursor to E-series resolvins, bioactive lipid mediators that actively promote the resolution of inflammation rather than just moderating its intensity. This pro-resolving function is distinct from and more sophisticated than simple anti-inflammatory activity, and it represents one of EPA’s most significant biological contributions.

The clinical research most strongly implicating EPA specifically includes mood and depression (where EPA-dominant formulations show the most consistent antidepressant effects), cardiovascular outcomes (where high-dose EPA-only therapy in the REDUCE-IT trial produced dramatic results), joint pain management, and airway inflammation in athletes. The detailed comparison of DHA and EPA covers the research distinctions between the two marine omega-3s in more depth for anyone who wants the full picture on which one to prioritize for a specific goal.

DHA: The Structural Omega-3

Docosahexaenoic acid (DHA) is a 22-carbon omega-3 fatty acid with six double bonds, making it the longest and most unsaturated of the three major omega-3s. Like EPA, it is found almost exclusively in marine sources. Unlike EPA, whose primary roles are regulatory, DHA’s primary roles are structural. It is one of the dominant fatty acids in the cell membranes of tissues with the highest functional demands: the brain’s neuronal membranes, the retina’s photoreceptor cells, and sperm cells.

In these tissues, DHA’s molecular structure confers specific physical properties to cell membranes that are essential for their function. The six double bonds create a highly flexible, kinked molecular shape that gives membranes an exceptional degree of fluidity. This fluidity enables the rapid conformational changes in membrane proteins, including neurotransmitter receptors in the brain and visual pigment proteins in the retina, that underlie cognitive function and visual signal transduction respectively. No other fatty acid substitutes for DHA in these structural roles at an equivalent level of efficiency.

DHA is also the precursor to D-series resolvins and protectins (also called neuroprotectins in neural tissue), which promote the resolution of inflammation through mechanisms distinct from the E-series resolvins produced by EPA. DHA’s contribution to inflammatory resolution adds a functional dimension to its primarily structural role.

The clinical applications where DHA shows the most specific effects include fetal and infant brain and retinal development (where DHA supply from mother is critical during gestation and nursing), cognitive aging and brain volume maintenance in older adults, visual health and macular degeneration risk reduction, and cognitive function enhancement in people with low baseline omega-3 status. DHA is also the omega-3 most studied in the context of prenatal supplementation, largely because it can be obtained from algae oil without the mercury concerns that complicate high fish consumption during pregnancy.

How the Three Relate to Each Other in Metabolism

ALA, EPA, and DHA sit in a metabolic relationship where ALA is the starting point and EPA and DHA are downstream products that can theoretically be produced from it. The pathway goes: ALA is elongated and desaturated to EPA, which is further elongated and desaturated to DHA. Each step requires specific enzymes (primarily delta-6-desaturase and delta-5-desaturase) that are shared with the omega-6 pathway and are rate-limiting for the whole system.

This metabolic relationship creates several important practical implications. First, omega-6 fatty acids (primarily linoleic acid from vegetable oils) compete with ALA at the same enzymes, and when omega-6 intake is high, ALA conversion to EPA and DHA is further suppressed. Second, DHA can be retroconverted to EPA in limited amounts, providing a modest back-pathway that does not fully compensate for inadequate EPA intake but does mean that DHA supplementation does not leave EPA stores completely empty. Third, the conversion is one-directional (ALA to EPA to DHA) with no reverse pathway; EPA and DHA cannot be converted back to ALA.

The most important practical takeaway from this metabolic picture is that consuming ALA does not reliably produce adequate EPA or DHA, and consuming DHA does not necessarily mean EPA is adequate, though the retroconversion provides some EPA from DHA. The safest approach for anyone who cannot obtain EPA and DHA from diet is to supplement both directly, rather than assuming that supplementing one or taking ALA will be sufficient for all omega-3 needs.

Summarizing the Differences

ALA is an essential 18-carbon plant-based omega-3 that provides ALA itself and serves as a precursor to EPA and DHA, but converts too inefficiently to substitute for direct EPA or DHA intake. It is found in flaxseed, chia, hemp, and walnuts, and meeting ALA requirements from diet is achievable for most people.

EPA is a 20-carbon marine omega-3 found primarily in fatty fish and algae oil, with primarily anti-inflammatory and pro-resolving roles. It drives the mood, cardiovascular, joint, and inflammatory resolution effects most associated with omega-3 in clinical research. It is not reliably obtained from plant foods through ALA conversion.

DHA is a 22-carbon marine omega-3 found in fatty fish and algae oil, with primarily structural roles in brain, retinal, and other high-demand tissues. It drives the neurological, visual, and cognitive effects associated with omega-3, and is the omega-3 most critical during pregnancy for fetal development. It is not reliably obtained from plant foods through ALA conversion.

For practical supplementation purposes, this means that people who do not eat fatty fish regularly need a direct source of preformed EPA and DHA from either fish oil or algae oil. Algae oil is the only option that provides both from a plant-based source, making it the essential supplement choice for vegans, vegetarians, and anyone avoiding fish for any reason.

The Bottom Line

ALA, EPA, and DHA are three distinct omega-3 fatty acids with different structures, different dietary sources, and different biological roles. They are not interchangeable. ALA is abundant in plant foods and serves as a precursor to EPA and DHA, but the conversion is too inefficient to substitute for direct intake. EPA is the anti-inflammatory marine omega-3 most relevant for mood, cardiovascular, and joint health. DHA is the structural marine omega-3 most relevant for brain, eye, and cognitive health. Adequate omega-3 status in the biologically important sense requires adequate EPA and DHA specifically, obtainable from fatty fish or from algae oil for those who do not eat fish.

Sources

• Burdge, G.C., and Calder, P.C. (2005). Conversion of alpha-linolenic acid to longer-chain polyunsaturated fatty acids in human adults. Reproduction Nutrition Development, 45(5), 581-597.
• Calder, P.C. (2012). Mechanisms of action of (n-3) fatty acids. Journal of Nutrition, 142(3), 592S-599S.
• National Institutes of Health, Office of Dietary Supplements. Omega-3 Fatty Acids: Fact Sheet for Health Professionals.

Frequently Asked Questions

What is the difference between ALA, EPA, and DHA?

ALA is an 18-carbon plant-based omega-3 found in flaxseed, chia, and walnuts. It is essential in the strictest sense but converts to EPA and DHA too inefficiently to substitute for direct marine omega-3 intake. EPA is a 20-carbon marine omega-3 with primarily anti-inflammatory and pro-resolving functions, most relevant to mood, cardiovascular, and joint health. DHA is a 22-carbon marine omega-3 with primarily structural functions in brain and retinal cell membranes, most relevant to cognitive and visual health.

Can your body convert ALA to DHA and EPA?

Yes, but only very inefficiently. Research estimates three to ten percent of ALA converts to EPA, and less than one percent reaches DHA. The conversion is further reduced by high omega-6 intake, which competes for the same enzymes. In practice, ALA from plant foods does not meaningfully raise EPA or DHA tissue levels, making direct supplementation necessary for people who do not eat fatty fish.

Which omega-3 is most important: ALA, EPA, or DHA?

All three are important, but for different reasons. ALA is technically essential in that the body cannot produce it at all. EPA and DHA are conditionally essential, meaning they can theoretically be produced from ALA but the conversion is so inefficient that direct intake is practically necessary for most people. For the health outcomes most associated with omega-3 supplementation, EPA and DHA are the operationally important fatty acids. For people who eat no marine foods, adequacy of all three requires both ALA-rich plant foods and algae oil supplementation.

Is flaxseed oil a good omega-3 supplement?

Flaxseed oil is a good source of ALA, which is a genuine omega-3 essential fatty acid. However, it does not provide EPA or DHA, and the body’s conversion of ALA to these longer-chain fatty acids is too inefficient to substitute for direct intake. As a source of ALA specifically, flaxseed oil is effective. As a substitute for EPA and DHA supplementation, it is not, regardless of how much is consumed.